Bank Of New York Mellon Corp Rubius Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$528 Trillion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.14 - $0.31 $2,938 - $6,506	20,990 New	20,990 $3,000
Q2 2022 Aug 15, 2022	SELL	$0.79 - $5.98 $99,750 - $755,076	-126,267 Reduced 85.75%	20,990 $18,000
Q1 2022 May 11, 2022	SELL	$4.25 - $10.4 $4,262 - $10,431	-1,003 Reduced 0.68%	147,257 $811,000
Q4 2021 Feb 11, 2022	SELL	$9.68 - $17.74 $409,938 - $751,271	-42,349 Reduced 22.22%	148,260 $1.44 Million
Q3 2021 Nov 12, 2021	SELL	$17.6 - $25.91 $369,459 - $543,902	-20,992 Reduced 9.92%	190,609 $3.41 Million
Q2 2021 Aug 11, 2021	BUY	$22.26 - $28.43 $416,440 - $531,868	18,708 Added 9.7%	211,601 $5.17 Million
Q1 2021 May 13, 2021	BUY	$8.02 - $32.01 $281,365 - $1.12 Million	35,083 Added 22.23%	192,893 $5.11 Million
Q4 2020 Feb 09, 2021	BUY	$4.23 - $8.73 $29,330 - $60,533	6,934 Added 4.6%	157,810 $1.2 Million
Q3 2020 Nov 12, 2020	SELL	$4.65 - $6.25 $1,618 - $2,175	-348 Reduced 0.23%	150,876 $755,000
Q2 2020 Aug 12, 2020	BUY	$4.01 - $6.88 $80,412 - $137,964	20,053 Added 15.29%	151,224 $904,000
Q1 2020 May 06, 2020	SELL	$3.74 - $9.84 $32,216 - $84,761	-8,614 Reduced 6.16%	131,171 $583,000
Q4 2019 Feb 14, 2020	BUY	$7.23 - $14.12 $105,051 - $205,163	14,530 Added 11.6%	139,785 $1.33 Million
Q3 2019 Nov 07, 2019	BUY	$7.85 - $15.75 $29,508 - $59,204	3,759 Added 3.09%	125,255 $983,000
Q2 2019 Aug 12, 2019	BUY	$13.5 - $19.94 $446,742 - $659,854	33,092 Added 37.43%	121,496 $1.91 Million
Q1 2019 May 14, 2019	BUY	$13.27 - $18.51 $671,183 - $936,217	50,579 Added 133.72%	88,404 $1.6 Million
Q4 2018 Feb 11, 2019	BUY	$13.83 - $22.97 $115,577 - $191,960	8,357 Added 28.36%	37,825 $609,000
Q3 2018 Nov 09, 2018	BUY	$20.06 - $26.94 $591,128 - $793,867	29,468 New	29,468 $0

Others Institutions Holding RUBY

# of Institutions

Shares Held

325

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

325
Shares

$0
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Rubius Therapeutics, Inc.

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

More about RUBY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account